Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· May 14, 2026

Ideal Power Reports First Quarter 2026 Financial Results

View original at finance.yahoo.com
Ideal Power Reports First Quarter 2026 Financial Results AUSTIN, Texas, May 14, 2026 /PRNewswire/ -- Ideal Power Inc…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Ideal Power is on track to complete the Stellantis deliverables under its existing purchase order by mid-2026.

    60% confidence
  • B-TRAN® is uniquely positioned to address the emerging opportunities created by the industry's transition toward next-generation, high-voltage DC power architectures.

    60% confidence
  • We had a strong start to the year as we initiated two additional projects with our lead Asia customer, signed a letter of intent with an industry partner to co-develop a B-TRAN®-enabled prototype for evaluation by a U.S. hyperscaler supporting the new NVIDIA Rubin Ultra 800V DC AI data center power distribution architecture, advanced Stellantis deliverables on schedule, and engaged on new opportunities with several multinational customers.

    60% confidence
  • Ideal Power currently holds 103 issued B-TRAN® patents, with 50 of those issued outside of the United States, covering North America, China, Taiwan, Japan, South Korea, India, and Europe.

    60% confidence
  • B-TRAN® intelligent SSCB prototype for U.S. hyperscaler evaluation is targeted for delivery at end of Q4 2026.

    60% confidence
  • Ideal Power's focus remains on converting its expanding sales funnel into production orders, revenue growth and long-term shareholder value creation.

    60% confidence
  • The industry's transition toward next generation, high-voltage DC power architectures is real and in its early stages, creating what we believe will be a significant demand for advanced solid-state power solutions.

    60% confidence
  • Low current SSCB prototype units expected to be available for 800V AI data center and energy grid customers in Q4 2026.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com